{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:48:37Z","timestamp":1787237317600,"version":"build-2736575974"},"reference-count":0,"publisher":"Journal of Biological Methods","issue":"1","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bladder"],"abstract":"<jats:p>Background: Robotic intracorporeal Studer orthotopic neobladder (RISON) is a complex procedure for bladder reconstruction. Objective: This study aimed to retrospectively examine the oncological\/functional outcomes, and complications of RISON at a single center. Methods: Baseline data and perioperative results of patients who received RISON between March 2018 and December 2022 were analyzed. Sixty-two cases (60 males, 2 females), with a mean age of 56.79 &amp;plusmn; 9.12 years, were included in the study. Follow-up data regarding RISON&amp;rsquo;s therapeutic effects, including tumor outcomes, neobladder capacity, continence, and complications, were collected. Results: All patients underwent the procedure without conversion to open surgery or changes in urinary diversion. The mean operative time lasted 379.2 &amp;plusmn; 88.8 min, with a median blood loss of 200 mL (range: 100&amp;ndash;300 mL). Indwelling time of the Ryles tube was 3.78 &amp;plusmn; 2.23 days, and post-operative hospital stay was 10 days (range: 8&amp;ndash;12 days). Pathological examination showed 87.1% (54\/62) of cases had T2N0M0 tumors. A mean of 17.42 &amp;plusmn; 8.03 lymph nodes were dissected, with three cases developing lymph node metastasis. Short-term complications (within 30 days) occurred in 51.9% of patients, while long-term complications (after 30 days) were found in 51.9% of patients. The mean neobladder volume measured 344.31 &amp;plusmn; 147.00 mL. Daytime continence was achieved in 88.2% of patients, and night-time continence was attained in 39.2%. The average night-time urinary frequency was 2.78 &amp;plusmn; 1.55 times, with 1.9 urine pads used on average. Follow-up duration ranged from 27 to 73 months, with a median time of 52.5 months. Five patients died of tumor metastasis, spreading to bone, liver, lung, brain, or lymph nodes. The 36- and 60-month cumulative recurrence-free survival rates were 96.3% and 87.4%, respectively. The 36- and 60-month cumulative overall survival rates were 96.3% and 90.4%, respectively. Conclusion: Clinically, RISON is a safe and feasible procedure with excellent oncological and functional outcomes, showing promise for widespread application.<\/jats:p>","DOI":"10.14440\/bladder.2024.0025","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T02:03:56Z","timestamp":1736906636000},"page":"e21200029","source":"Crossref","is-referenced-by-count":2,"title":["Oncological and functional outcomes and complications of robotic intracorporeal Studer orthotopic neobladder: A single-center retrospective study"],"prefix":"10.14440","volume":"12","author":[{"given":"Qiang","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xupeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5574","published-online":{"date-parts":[[2025,1,9]]},"container-title":["Bladder"],"original-title":[],"link":[{"URL":"https:\/\/web-api.polscientific.com\/uploads\/file\/asp\/20250314161011d8fc84998.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/web-api.polscientific.com\/uploads\/file\/asp\/20250314161011d8fc84998.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T05:49:48Z","timestamp":1741931388000},"score":1,"resource":{"primary":{"URL":"https:\/\/polscientific.com\/journal\/Bladder\/12\/1\/10.14440\/bladder.2024.0025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2,28]]}},"URL":"https:\/\/doi.org\/10.14440\/bladder.2024.0025","relation":{},"ISSN":["2327-2120"],"issn-type":[{"value":"2327-2120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]}}}